Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial (vol 398, pg 843, 2021)

Yu L-M., Bafadhel M., Dorward J.

DOI

10.1016/S0140-6736(21)01889-4

Type

Journal article

Journal

LANCET

Publication Date

04/09/2021

Volume

398

Pages

E12 - E12

Permalink Original publication